PRP vs 5% Topical Minoxidil: A Dilemma in Moderate Male Androgenetic Alopecia

This article evaluates the effectiveness of autologous platelet-rich plasma (PRP) versus 5% topical minoxidil in treating male androgenetic alopecia (AGA), a condition affecting up to 50% of men by age 50 and linked to psychosocial burdens. The review of randomized controlled trials, systematic reviews, and clinical studies reveals that neither PRP nor minoxidil consistently outperforms the other as a standalone treatment. However, a combination therapy approach tends to yield superior outcomes for managing male AGA.